Coagulation defects in neonates during cardiopulmonary bypass
- PMID: 1510523
- DOI: 10.1016/0003-4975(92)90451-9
Coagulation defects in neonates during cardiopulmonary bypass
Abstract
We examined components of the coagulation system in 30 neonates (age, 1 to 30 days) undergoing deep hypothermic cardiopulmonary bypass (CPB). A coagulation profile consisting of activated clotting time; prothrombin time; partial thromboplastin time; factors II, V, VII, VIII, IX, X, and I (fibrinogen); antithrombin III; platelet count; and heparin levels was evaluated before bypass, at three intervals during bypass (1 minute after initiation of bypass, stable hypothermic CPB, warm CPB), after weaning from CPB and administration of protamine, and 2 to 3 hours after skin closure. The initiation of CPB resulted in a 50% decrease in circulating coagulation factors and antithrombin III levels. Platelet counts were reduced by 70% with CPB initiation. Neither deep hypothermic temperatures nor prolonged exposure to extracorporeal surfaces had any additional effect on the coagulation profiles. This suggests that the coagulation system of a neonate undergoing CPB is profoundly and globally effected by hemodilution. We believe that treatment of post-CPB coagulopathy in neonates must address these global deficits.
Comment in
-
Coagulation defects in neonates during cardiopulmonary bypass.Ann Thorac Surg. 1993 May;55(5):1283-4. doi: 10.1016/0003-4975(93)90073-q. Ann Thorac Surg. 1993. PMID: 8338580 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
